2,920 reports of this reaction
3.9% of all PIOGLITAZONE reports
#3 most reported adverse reaction
NAUSEA is the #3 most commonly reported adverse reaction for PIOGLITAZONE, manufactured by Takeda Pharmaceuticals America, Inc.. There are 2,920 FDA adverse event reports linking PIOGLITAZONE to NAUSEA. This represents approximately 3.9% of all 74,368 adverse event reports for this drug.
PIOGLITAZONE has an overall safety score of 85 out of 100. Patients taking PIOGLITAZONE who experience nausea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NAUSEA is moderately reported among PIOGLITAZONE users, representing a notable but not dominant share of adverse events.
In addition to nausea, the following adverse reactions have been reported for PIOGLITAZONE:
The following drugs have also been linked to nausea in FDA adverse event reports:
NAUSEA has been reported as an adverse event in 2,920 FDA reports for PIOGLITAZONE. This does not prove causation, but indicates an association observed in post-market surveillance data.
NAUSEA accounts for approximately 3.9% of all adverse event reports for PIOGLITAZONE, making it one of the most commonly reported side effect.
If you experience nausea while taking PIOGLITAZONE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.